Microbot Medical Reports Officer/Director Changes, Comp Arrangements
Ticker: MBOT · Form: 8-K · Filed: Jan 12, 2024 · CIK: 883975
| Field | Detail |
|---|---|
| Company | Microbot Medical Inc. (MBOT) |
| Form Type | 8-K |
| Filed Date | Jan 12, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: executive-changes, compensation, corporate-governance
TL;DR
**Microbot Medical just reported executive changes and new pay deals, watch for details.**
AI Summary
Microbot Medical Inc. filed an 8-K on January 12, 2024, reporting an event that occurred on January 8, 2024, related to changes in its directors or certain officers and their compensatory arrangements. This filing indicates potential shifts in leadership or executive compensation, which could impact the company's strategic direction and financial health. Investors should pay attention to the specific details of these changes, as they can signal future performance or operational stability.
Why It Matters
Changes in leadership and executive compensation can significantly influence a company's strategy, operational efficiency, and ultimately, its stock performance. Investors need to understand who is leading the company and how they are incentivized.
Risk Assessment
Risk Level: medium — Changes in leadership can introduce uncertainty, but without specific details on who departed or was appointed, the immediate risk is moderate.
Analyst Insight
A smart investor would await further details on the specific individuals involved in the leadership changes and the nature of the compensatory arrangements to assess potential impacts on company strategy and financial health.
Key Players & Entities
- Microbot Medical Inc. (company) — the registrant filing the 8-K
- January 8, 2024 (date) — date of the earliest event reported
- January 12, 2024 (date) — date the 8-K was filed
FAQ
What specific event did Microbot Medical Inc. report in this 8-K filing?
Microbot Medical Inc. reported events related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' and 'Compensatory Arrangements of Certain Officers' as per Item 5.02 of Form 8-K.
When did the earliest event reported in this 8-K filing occur?
The earliest event reported in this 8-K filing occurred on January 8, 2024.
What is the filing date of this 8-K?
This 8-K was filed on January 12, 2024.
What is Microbot Medical Inc.'s business address?
Microbot Medical Inc.'s business address is 288 Grove Street, Suite 388, Braintree, MA 02184.
What is the company's telephone number?
The registrant's telephone number is (781) 875-3605.
Filing Stats: 484 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2024-01-12 16:20:41
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value MBOT The Nasdaq Capital M
Filing Documents
- form8-k.htm (8-K) — 37KB
- 0001493152-24-002201.txt ( ) — 206KB
- mbot-20240108.xsd (EX-101.SCH) — 3KB
- mbot-20240108_lab.xml (EX-101.LAB) — 33KB
- mbot-20240108_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MICROBOT MEDICAL INC. /s/ Harel Gadot Harel Gadot Chairman, President and Chief Executive Officer Date: January 12, 2024